Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T09:12:45.343Z Has data issue: false hasContentIssue false
  • English
  • Français

Adverse Drug Reactions to First- and Second-Generation Antidepressants: A Critical Evaluation of Drug Surveillance Data

Published online by Cambridge University Press:  29 January 2018

Lutz G. Schmidt ,
R. Grohmann ,
B. Müller-Oerlinghausen ,
H. Ochsenfahrt  and
P. S. Schönhöfer
Lutz G. Schmidt*
Affiliation:
Department of Psychiatry of the Free University of Berlin, Eschenallee 3, D-1000 Berlin 19 (West), Germany
R. Grohmann
Affiliation:
Department of Psychiatry of the University of Munich
B. Müller-Oerlinghausen
Affiliation:
Department of Psychiatry of the Free University of Berlin
H. Ochsenfahrt
Affiliation:
Medicines Commission of the German Medical Profession, Cologne
P. S. Schönhöfer
Affiliation:
Bremen
*
Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

We reviewed data on adverse drug reactions (ADRs) to first- and second-generation antidepressants, recorded by two different drug surveillance systems. The rate of ADRs that led to discontinuation of the drug in the individual case, assessed within a multi-centred hospital-based drug monitoring system (AMüP), was significantly higher in case of exposure to tricyclics (7.4%) than with the second-generation drugs (3.1%). On the basis of voluntary reports to the Medicines Commission of the German Medical Profession (AMK), profiles of ADRs to the drugs under survey were constructed and compared with data compiled by the WHO. The types of ADRs varied more between second-generation drugs than between tricyclics. Special attention was paid to rare but serious ADRs (e.g. seizures during treatment with maprotiline, and blood dyscrasias attributed to mianserin).

Type
Papers
Information
The British Journal of Psychiatry , Volume 148 , Issue 1 , January 1986 , pp. 38 - 43
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (1981) Das AMPD-Syslem 4th ed. Berlin: Springer Verlag.Google Scholar
Grohmann, R., Strauss, A., Gehr, C., Rüther, E. & Hippius, H. (1980) Zur Praxis der klinischen Therapie mit Psychopharmaka. Pharmacopsychiatry, 13, 1–19.Google Scholar
Grohmann, R., Hippius, H., Müller-Oerlinghausen, B., Rüther, E., Scherer, S., Schmidt, L. G., Strauss, A. & Wolf, B. (1984) Assessment of adverse drug reactions in psychiatric hospitals. European Journal of Clinical Pharmacology, 26, 727–734.CrossRefGoogle ScholarPubMed
Grüter, W. & Pöldinger, W. (1982) Maprotiline. Modern Problems of Pharmacopsychiatry (Basel), 18, 17–48.Google ScholarPubMed
Hurwitz, N. & Wade, O. L. (1969) Intensive hospital monitoring of adverse reactions to drugs. British Medical Journal, 1, 531–536.Google Scholar
Inman, W. H. W. (1980) Monitoring for Drug Safety. Lancaster: MTP Press.Google Scholar
Karch, F. E. & Lasagna, L. (1975). Adverse drug reactions. Journal of the American Medical Association, 234, 1236–1241.Google Scholar
Nilson, B. S. (1983) Adverse reactions to zimelidine treatment. Acta Psychiatrica Scandinavica, 38, Supplementum 308, 115–119.CrossRefGoogle Scholar
Rüther, E., Benkert, O., Eckmann, F., Eckmann, J., Grohmann, R., Helmchen, H., Hippius, H., Müller-Oerlinghausen, B., Poser, W., Schmidt, L. G., Stille, G., Strauss, A. & Überla, K. (1980) Drug monitoring in psychiatrischen Kliniken. Arzneimittel-Forschung/Drug Research, 30, 1181–1183.Google Scholar
Schmidt, L. G., Niemeyer, R. & Müller-Oerlinghausen, B. (1983) Drug prescribing pattern of a psychiatric university hospital in Germany. Pharmacopsychiatry, 16, 35–42.CrossRefGoogle ScholarPubMed
Schmidt, L. G., Grohmann, R., Helmchen, H., Lanoscheid-Schmidt, K., Müller-Oerlinghausen, B., Poser, W., Rüther, E., Scherer, J., Strauss, A. & Wolf, B. (1984) Adverse drug reaction: An epidemiological study at psychiatric hospitals. Acta Psychiatrica Scandinavica, 70, 77–89.Google Scholar
Seidl, L. G., Thornton, G. F. & Cluff, L. E. (1965) Epidemiological studies of adverse drug reactions. American Journal of Public Health, 55, 1170–1175.Google Scholar
Venulet, J. (1979) Monitoring adverse drug reactions—the problem of integration of heterogeneous data. International Journal of Clinical Pharmacology and Biopharmacy, 17, 383–386.Google ScholarPubMed
Weber, J. C. P. (1984) Epidemiology of adverse reactions to nonsteroidal antiflammatory drugs In Advances in Inflammation Research, ed. Rainsford, K. D. & Velo, G. P. New York: Raven Press.Google Scholar
Wells, B. G. & Gelenberg, A. J. (1981) Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride. Pharmacotherapy, 1, 121–139.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.